Skip to main content
Premium Trial:

Request an Annual Quote

LGC Acquires Link Technologies

NEW YORK (GenomeWeb) – Life sciences tools provider LGC said today that it has acquired Link Technologies, a supplier of specialty reagents for oligonucleotide synthesis.

Following the acquisition, LGC plans to form a new Nucleic Acid Chemistry business unit within its Genomics division that combines Link with its existing Biosearch oligo reagent group and Prime Synthesis CPG business.

Brian Kim, president and managing director of the LGC Genomics division, said in a statement that Link's products are a "great complement" to LGC's, and will provide customers with "an expanded product range, increased supply chain security, improved global logistics, and industry-leading customer support."

Link's customers include oligo synthesis companies, university and commercial research departments, and others in the biotech sector, LGC added.